Civic Intelligence

Association for Precision Pharmacy

990 • Fiscal year 2017 • EIN 47-5288440

Jan 01, 2017 to Dec 31, 2017

San Antonio, TX
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

47th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2017 filings • 501(c)6 • <$500k nonprofits • Source year 2017

Liabilities / Revenue

47th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2017 filings • 501(c)6 • <$500k nonprofits • Source year 2017

Net Margin

13th percentile

-21%

Higher net margin than 13% of similar nonprofits.

2017 filings • 501(c)6 • <$500k nonprofits • Source year 2017

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2017

Asset Growth

100th percentile

2548%

Faster asset growth than 100% of similar nonprofits.

2017 filings • 501(c)6 • <$500k nonprofits • Annualized from 2015 to 2017

Revenue Growth

Score unavailable

No value available

A valid growth rate could not be computed from the available filing history.

Annualized from 2015 to 2017

Assets

Up

$701

Up $700 (+70000%) from 2015

Net Assets

$701

No earlier filing loaded for comparison.

Liabilities

Flat

$0

Flat from 2015

Revenue

Up

$26,698

Up $26,698 from 2015

Expenses

Up

$32,307

Up $32,307 from 2015

Net Income

Down

-$5,609

Down $5,609 from 2015

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$100K$50K$0-$50KAssets 2015: $1Liabilities 2015: $02015Assets 2017: $701Liabilities 2017: $0Net Assets 2017: $7012017Assets 2018: $21,925Liabilities 2018: $0Net Assets 2018: $21,9252018Assets 2020: $53,147Liabilities 2020: $52,058Net Assets 2020: $1,0892020Assets 2021: $76,748Liabilities 2021: $93,964Net Assets 2021: -$17,2162021

Highlighted filing

2017

Assets$701
Liabilities$0
Net Assets$701

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500KRevenue 2015: $0Expenses 2015: $0Net Income 2015: $02015Revenue 2017: $26,698Expenses 2017: $32,307Net Income 2017: -$5,6092017Revenue 2018: $924,449Expenses 2018: $903,225Net Income 2018: $21,2242018Revenue 2020: $634,153Expenses 2020: $658,789Net Income 2020: -$24,6362020Revenue 2021: $144,252Expenses 2021: $162,557Net Income 2021: -$18,3052021

Highlighted filing

2017

Revenue$26,698
Expenses$32,307
Net Income-$5,609
Filing Detail Status

This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2017 to Dec 31, 2017
Mission and Program Overview

Mission

To conduct effective advocacy for public policies that encourage the implementation of practices and technologies directed by pharmacists and biotechnology companies that minimize side effects and improve overall patient outcomes, and to support the needs of our members that represent the precision medicine industry.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings